A compound according to Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R11, L1 and X are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
申请公布号
US8163771(B2)
申请公布日期
2012.04.24
申请号
US20090381682
申请日期
2009.03.13
申请人
MARTIN RICHARD;FLATT BRENTON T.;DALGARD JACKLINE EVE;BOLLU VENKATAIAH;HUANG PING;MOHAN RAJU;SCHWEIGER EDWIN;WANG TIE-LIN;EXELIXIS, INC.
